Cannabis

Global spending on legal cannabis is expected to grow 230% to $31.3% billion in 2022 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. The research projects a majority of that, nearly $23.4 billion will come from the United States. In context of more states voting in favor of marijuana use legalization and business interest sparking across the board, that definitely would make sense.

In the year through January 11, 2019, the United States Marijuana Index, fell 20.7%, as compared to about 6.5% loss seen by the S&P 500. Given that is not exactly an apples to apples comparison, but it does make a case to at least investigate investments in marijuana stocks. (May 6, 2019, Mrinalini Krishna, Investopedia)

It has been a difficult year for Canadian cannabis stock with most of them burning significant investor wealth in the past year and the recent coronavirus pandemic seemed to have worsened thing. Industry operators have faced capital problems and most have been left grappling with debt. As a result,...
With the coronavirus ravaging the markets Canadian cannabis stocks have been some of the most effects. It is expected that we will see several losers but there will be some winners who will emerge after the COVID-19 pandemic strong. Even before the pandemic, the Canadian cannabis sector was performing...
Despite the legalization of recreational use, Canadian cannabis stocks have faced a myriad of challenges. Cannabis operators have faced regulatory challenges that have derailed the issuance of growing and retail store licenses with provinces such as Ontario lagging in retail store licensing which has caused a supply bottleneck in...
Canadian cannabis companies were expecting to capitalize on opportunities such as legalization of derivatives but it seems the COVID-19 pandemic will derail those opportunities. However, although there have been delays in the launch of derivatives and the opening of more stores the industry has benefitted from a surge in...
The coronavirus pandemic has hit the world hard and it is affecting every sector including the cannabis industry. Cannabis operators have to contend with this new reality which has disrupted the industry in various ways. The pandemic has worsened the situation for an industry that has been battling problems...
Coronavirus pandemic has swept across over 200 countries and its economic impact is felt in various sectors the cannabis industry included. The cannabis industry has been facing challenges in the past year but the COVID-19 pandemic has just turned it into a dumpster fire. Although the pandemic has affected...
Following the coronavirus outbreak, various countries have imposed measures such as locking all non-essential businesses and restricting the movement of people to combat spread. However, for the Canadian cannabis business, they are still operating as usual as the government considers them essential services. Most of the Canadian governments have...
The coronavirus pandemic has triggered one of the biggest market crash in recent history.  Stock market indices are already down by more than 20% and officially in bear territory. Amidst growing concerns about the global economic recession, investments in the stock markets are slowly drying up.  As bleak things...
The coronavirus pandemic has triggered one of the biggest corrections in the equity markets in recent history. With the correction, so are a number of investment opportunities cropping up especially in the burgeoning Canadian cannabis industry that continues to experience an increase in sales. MediPharm Labs Corp (TSE: LABS),...
The Canadian cannabis industry had a terrible 2019 where most cannabis operators burnt significant investor wealth. Over the past few weeks, the coronavirus outbreak has affected markets and cannabis stocks have not been spared either. Although the impact the pandemic might have on revenues of cannabis operators is debatable...